"Page 4 - to be considered a great clinical outcome, phase 2a just needs 25% of patients to show a significant reduction in proteinuria"
There are a few quotes like this in the presentation - looks like the company is very confident with results and is looking at potential takeover offers given that they already have a timeline for partnership/takeover next steps
Ann: Investor Update, page-15
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
51.0¢ |
Change
0.035(7.37%) |
Mkt cap ! $280.6M | |||
| Open | High | Low | Value | Volume |
| 47.5¢ | 54.0¢ | 47.5¢ | $3.360M | 6.544M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 25428 | 51.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 51.5¢ | 15478 | 1 |
View Market Depth
| Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
| DXB (ASX) Chart |